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Dosage compensation in Drosophila is mediated by
the MSL complex, which increases male X-linked
gene expression approximately 2-fold. The MSL
complex preferentially binds the bodies of active
genes on the male X, depositing H4K16ac with a 30
bias. Two models have been proposed for the influ-
ence of the MSL complex on transcription: one
based on promoter recruitment of RNA polymerase
II (Pol II), and a second featuring enhanced transcrip-
tional elongation. Here, we utilize nascent RNA
sequencing to document dosage compensation dur-
ing transcriptional elongation. We also compare X
and autosomes from published data on paused and
elongating polymerase in order to assess the role
of Pol II recruitment. Our results support a model
for differentially regulated elongation, starting with
release from 50 pausing and increasing through
X-linked gene bodies. Our results highlight facilitated
transcriptional elongation as a key mechanism for
the coordinated regulation of a diverse set of genes.
INTRODUCTION
In Drosophila melanogaster, expression from the single male X
chromosome (XY) is upregulated about 2-fold to match tran-
scription of the two Xs in females (XX). This process, termed
dosage compensation (DC), makes X-linked transcription equiv-
alent between the sexes and also balances X and autosomal
transcription (Gupta et al., 2006; reviewed in Lucchesi et al.,
2005; Gelbart and Kuroda, 2009). Upregulation of the male X is
mediated by the MSL complex, which consists of at least five
protein subunits (MSL1, MSL2, MSL3, MLE, and MOF) and two
noncoding RNAs (roX1 and 2) (reviewed in Gelbart and Kuroda,Ce2009). MOF has histone acetyltransferase activity and modifies
histone 4 at lysine 16 (H4K16), enriching this mark along the
male X (Gu et al., 1998; Smith et al., 2000). H4K16ac is thought
to play a key role in the upregulation of genes on the male X
because it enhances transcription in vitro and in vivo (Akhtar
and Becker, 2000; Smith et al., 2001; Dou et al., 2005).
The steps in transcription that are targeted by the DC mecha-
nism have been controversial. The major mechanistic steps in
transcription are listed in Figure 1A. In brief, recruitment of
RNA polymerase II (Pol II) to promoters by general transcription
factors is followed by conversion to an initiating complex via
TFIIB stimulation of RNA synthesis (Sainsbury et al., 2013).
Once the RNA grows to 12–13 nucleotides, it triggers TFIIB
displacement and elongation complex formation. However, in
Drosophila and mammals elongating Pol II subsequently pauses
on a majority of transcribed genes, with a prominent Pol II peak
seen around +50 relative to the TSS (reviewed in Gilmour, 2009).
Surprisingly, many highly expressed genes in Drosophila display
pausing, suggesting that it could be an obligate step during
active transcription, perhaps to allow time for association of
key elongation and splicing factors. Release of paused Pol II is
mediated by phosphorylation of NELF, DSIF, and serine 2 in
the C-terminal domain (CTD) of Pol II by the kinase P-TEFb (Pe-
terlin and Price, 2006). DSIF is composed of subunits SPT4 and
SPT5 that act positively in subsequent elongation by closing the
Pol II active cleft to render the elongation complex stable and
processive (Martinez-Rucobo et al., 2011). Transcription termi-
nation involves coordination between the exit of elongation fac-
tors and recruitment of cleavage and termination factors (Mayer
et al., 2010, 2012). There is no single method to simultaneously
analyze regulation of each of these steps of transcription in vivo.
However, recent advances allow a composite picture of regu-
lation genome-wide. In Figure 1A, we list these methods
(described below) and their abilities to distinguish between steps
in the transcription cycle.
Two competing models have been proposed for how MSL
complex can coordinately control hundreds of functionallyll Reports 5, 629–636, November 14, 2013 ª2013 The Authors 629
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Figure 1. Transcription Analysis
(A) Summary of genome-wide methods for
studying transcription is shown. Each method can
provide information about specific stages of tran-
scription (horizontal arrows). In some stages, and
especially in the initial phases (on the left), the
available methods do not allow discrimination
between different steps of transcription. These
resolution limitations are depicted as arrows
spanning boundaries between multiple stages.
The dashed arrow in ‘‘GRO-seq No Sarkosyl’’
indicates the lack of data for paused Pol II. ChIP
Pol II, chromatin immunoprecipitation targeting
Pol II followed by either sequencing (ChIP-seq) or
microarray hybridizations (ChIP-chip); Ser2P,
serine 2 phosphorylation marking elongating Pol II;
GRO-seq, global run-on sequencing with sarkosyl
treatment to detect paused and active Pol II or
without sarkosyl to detect active Pol II only; 50
RNAs, sequencing of short 50 capped nuclear
transcripts to measure 50 pausing; Nascent-seq,
sequencing of nascent transcripts.
(B) A schematic representation of the cDNA-based
and direct nascent RNA sequencing (DnRS) pro-
tocols is shown. Nascent transcripts were isolated
using the same protocol, followed by two different
sequencing approaches. In cDNA sequencing,
strand-specific cDNA is synthesized by random
priming of the entire nascent transcript, with a
resulting decrease in read density from the 50 end
to 30 end (red). In contrast, the 30 end of the
nascent transcript is sequenced directly in DnRS,
thus providing a precise map of Pol II position
(green).
See also Figure S1.unrelated genes: one focused on differential promoter recruit-
ment of Pol II (Conrad et al., 2012), and a second featured
enhanced transcriptional elongation (Larschan et al., 2011; Prab-
hakaran and Kelley, 2012). To distinguish between them, we
combine three high-resolution methods: 50 paused RNA
sequencing, GRO-seq, and Nascent-seq. For the recruitment
model, each should demonstrate a similar fold increase in X
versus autosomal signal along genes, indicating that DC is fully
implemented at the recruitment step. In contrast, the elongation
model predicts that a differential effect may be seen from 50 to 30.
Early steps such as 50 pausing may not be rate limiting and may
not exhibit compensation (e.g., XzA), whereas later steps may
show increasing compensation (e.g., X z2A). Thus, Pol II
behavior on X and autosomal genes in male cells should allow
us to discriminate between the two models.
RESULTS AND DISCUSSION
Male S2 and female Kc cells are robust models for the study of
DC in Drosophila. S2 cells express the MSL complex, which
binds to the bodies of X-linked genes (Alekseyenko et al.,
2006; Gilfillan et al., 2006) to increase their transcription (Ham-630 Cell Reports 5, 629–636, November 14, 2013 ª2013 The Authorsada et al., 2005; Straub et al., 2005). If
MSL2 is induced in female Kc cells, it
also increases X transcription relative toautosomes (Alekseyenko et al., 2012). However, female cells
normally do not express MSL2, and therefore levels of X tran-
scription are on average similar to autosomes (Conrad et al.,
2012, and see below). Thus, the key measurement for DC is
the differential behavior of the X and autosomes within male
cells.
The choice of method(s) is crucial (Figure 1A). Genome-wide
ChIP analysis of Pol II is commonly used to study its density
along genes; however, this approach is strongly dependent on
antibody quality and has limited resolution owing to fragmented
chromatin size. In addition, ChIP-seq does not allow a precise
distinction between different activity states of Pol II, although
antibodies for phosphorylated forms of the CTD can help distin-
guish between elongating or paused isoforms (Weeks et al.,
1993; Buratowski, 2009). In contrast, GRO-seq (Core et al.,
2008) is independent of antibody specificity and maps the posi-
tion and density of paused and elongating Pol II along genes in a
quantitative manner. A strength of this method is its ability to
measure transcriptionally engaged but paused Pol II at 50 ends
of genes. An independent assay for 50 pausing involves the isola-
tion and sequencing of short 50 capped nuclear transcripts (Ne-
chaev et al., 2010). Nascent-seq (Khodor et al., 2011) isolates Pol
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Figure 2. Nascent-Seq cDNA Analysis of Transcription in Male S2
Cells after Control or MSL RNAi
Average cDNA sequencing read-density profiles of actively transcribed X (red;
n = 379) and autosomal (blue; n = 1,538) genes in control RNAi (solid lines) and
MSL RNAi (dashed) samples in male (S2) cells are shown. The metagene
profile is generated by rescaling the gene body to a fixed width between
transcription start site (TSS) and transcript end (30 end), excluding introns.
Because intron removal reduces the size of the represented region, the whole
gene body is scaled; if unscaled, the 50 and 30 ends would leave little to no
central gene body for analysis.
See also Figure S2.II and nascent transcripts by virtue of their exceptional stability
on the chromatin template during transcription (Wuarin and Schi-
bler, 1994; Carrillo Oesterreich et al., 2010) and can be used as a
sensitive method to measure transcriptional elongation (see
below).
We prepared nascent transcripts (Wuarin and Schibler, 1994)
from control andMSL-RNAi-treated S2 cells, converted the RNA
samples to strand-specific cDNA, and sequenced the cDNA on a
HeliScope Single Molecule Sequencer. In the resulting profile,
the density of the sequenced reads reflects the nascent RNA
abundance. Assuming no RNA degradation, all nascent RNAs
for a given transcript share the same 50 end, but differ in their
30 end depending on the position of elongating Pol II. Therefore,
the abundance of RNA sequences should decrease from the 50
to the 30 ends of genes (Figure 1B), as shown for the roX2 gene
(Figure S1A). To summarize the genome-wide pattern, we
plotted the metagene profile of read densities, in which actively
transcribed genes > 2.5 kb long (> 0.5 kb after intron removal)
were rescaled to have the same length (Figure 2). The intronic
regions were removed because cotranscriptional splicing (Car-
rillo Oesterreich et al., 2010; Khodor et al., 2011; Bhatt et al.,
2012) results in underrepresentation of intron sequences, thus
distorting the profile related to Pol II processivity alone (Fig-
ure S2A). The profiles for cDNA sequencing show the expected
50 to 30 decline (Figure 2 and Figure S2B).
Male S2 cells have a relative X:A copy number ratio of 1:2.
However, we observed a relative increase in X chromosomeCesequencing reads approaching the level of autosomal reads (X
z2A), rather than being half as abundant (Figure 2 and Figures
S2C–S2D). In contrast, after MSL1 and MSL2 RNAi, we found
a decrease of X sequencing reads (red dashed line), which
now fail to approach the 2A autosomal level (Figure 2). Thus,
Nascent-seq successfully documents MSL-dependent DC at
the level of nascent X versus autosomal transcription. However,
sequencing cDNA derived from whole nascent transcripts did
not allow us to identify the stages in the transcription cycle where
critical differences occur.
To obtain a mechanistic picture of the affected steps, we
needed a method to map the position of elongating Pol II with
nucleotide resolution. We accomplished this by replicating
the Nascent-seq results using direct RNA sequencing (DRS)
(Ozsolak et al., 2009), designating this approach as direct
nascent RNA sequencing, or DnRS (see the Experimental Pro-
cedures). DnRS starts from and is restricted to the 30 end of
the isolated transcript, and thus the expected profile (Figures
1B and S1A, right) reflects the actual position of Pol II at nucleo-
tide resolution. We plotted the S2 cell DnRS metagene profile
of active genes longer than 2.5 kb (Figure 3A). Because only
the 30 end of the nascent transcript is sequenced, intron removal
is not necessary because cotranscriptional splicing does not
interfere with Pol II localization. The resulting average profile
shows progression of RNA Pol II along active genes (Figures
3A and 3B).
To determine which steps in transcription might be differ-
entially regulated on X and autosomes, we compared their
metagene profiles in S2 cells. When plotting the nascent RNA
abundance in cells with a relative X:A copy number of 1:2, we
found that there are fewer X-chromosomal (red) compared to
autosomal (blue) nascent transcript reads mapped to the 50
ends of the metagenes (Figure 3A), but the difference is less
than 2-fold, suggesting partial DC (X > A). As transcription
progresses, this difference narrows. In the last portion of the
metagene, nascent transcript reads increase on both X and
autosomes as Pol II approaches the 30 polyadenylation site,
possibly slowing in preparation for processing and termination
(Core et al., 2008; Carrillo Oesterreich et al., 2010; Mayer et al.,
2012). Interestingly, we found that X chromosomal nascent tran-
scription, reflecting Pol II density, approaches autosomal levels
(X z2A) (Figure 3C). This representation without gene body re-
scaling allows a better visualization of true absolute distances
from the gene end (Figure 3C). In contrast to male S2 cells,
DnRS of female Kc cells shows similar transcription of X and
autosomal genes (2X z2A) during all phases of transcription
(Figures 3B and 3D), validating our approach. We found these
results to be significant and robust over variations of several
analysis parameters, such as transcriptional threshold, gene
length, and distance to neighboring gene (Figure S3).
The simplest explanation for our results is that Nascent-seq
reveals increasing DC along the bodies of X-linked genes in
male cells, with increased density of Pol II at steady state
correlating with the increase in mRNA output. One possibility is
that H4K16ac increases retention of X-linked Pol II that might
otherwise prematurely terminate during elongation. Alterna-
tively, increased efficiency of successfully elongating Pol II
may result in positive feedback to Pol II molecules waiting toll Reports 5, 629–636, November 14, 2013 ª2013 The Authors 631
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Figure 3. Nascent-Seq DnRS Analysis of
Transcription in Male and Female Cells
(A and B) Average read-density profiles of actively
transcribed genes for DnRS data in male (S2) cells
(A) and female (Kc) cells (B) for the X (red; male n =
471, female n = 428) and autosomes (blue; male
n = 1,612, female n = 1,552) are shown. The
common genes between male and female are 405
and 1420 for X chromosome and autosomes,
respectively. The metagene profile is generated
by rescaling the gene coordinates to a fixed width
between TSS and 30 end. The initial and final
500 bp of genes is presented without scaling of
the coordinates.
(C and D) Average DnRS read density near the 30
end of actively transcribed genes (top panels) in
male (S2) cells (C) and female (Kc) cells (D) is
shown. Unscaled coordinates (real distance) for
the same genes are shown. Ratio between
average read density of X and autosomes is re-
ported in the bottom panels.
See also Figure S3.engage in earlier steps in the transcription cycle. Distinguishing
between these two possibilities will require future development
of methods to measure the kinetics of Pol II processivity
genome-wide, for example, by visualizing a single round of tran-
scription rather than the steady-state density of Pol II.
S2 and Kc cells are known to be polyploid (on average 2X:4A
and 4X:4A, respectively) and to harbor numerous variations in
copy number for individual genes. When assessing X to A tran-
scription above, we simply compared total X and autosomal
sequence reads per cell type because it is not possible to
normalize for direct RNA sequencing efficiency or biases using
genomic DNA sequencing. We also tested normalization by
gene copy number and observed similar results, possibly damp-
ened by a contribution from genome-wide compensation for
aneuploidy, previously observed in S2 cells (Zhang et al., 2010)
(Figures S4A and S4C). When assessing nascent RNA levels
from each chromosome arm separately, 3R appears to be an
outlier using correction per gene copy (Figure S4E), whereas
3L is an outlier using total read density (Figure S4G). The fourth
chromosome is also quite variable, but this has negligible effect
on the overall autosomal average because there are few active
genes on the fourth, accounting for only 2.7% of the autosomal
genes used in these analyses (Figure S4I). Because we observed
these normalization differences, we believe that the specific
values associated with X and A differences in our genomic ana-632 Cell Reports 5, 629–636, November 14, 2013 ª2013 The Authorslyses should be interpreted with caution.
However, the general trends, such as a
difference from 50 to 30 along X-linked
genes (Figure S3 and discussed below),
are consistent across all methods.
Nascent-seq demonstrated a clear
effect across gene bodies and also sug-
gested that regulation was starting early
in the transcription cycle. Precisely where
the regulation occurs, however, could not
be evaluated using this technique (Fig-ure 1A). Therefore, we analyzed potential X and autosome differ-
ences in initiation, 50 pausing, and pausing release using several
independent data sets from male S2 cells. We previously found
that the average X-chromosomal level of 50 pausedPol II is equiv-
alent to the average autosomal level inmale S2 cells byGRO-seq
analysis when normalized to gene dose (X = A), consistent with
lack of compensation at that step (Larschan et al., 2011). GRO-
seq can detect engaged but paused Pol II, which is released
from pausing by sarkosyl detergent. However, the large peaks
of promoter-proximal paused Pol II might mask differences in
nonpaused Pol II at early steps in transcription. Therefore, we
used recently published data (Core et al., 2012) in which S2 cells
were analyzed using two GRO-seq protocols: either the original
GRO-seq protocol (Figure 4A) or actively elongating RNA Pol II
only (GRO-seq protocol without sarkosyl treatment) (Figure 4B).
The independent GRO-seq data are concordant with our previ-
ous observations (with the original protocol), showing no
compensation of X-linked genes at the pausing step (Larschan
et al., 2011). The ratio over genomic sequencing control shows
that X = A at the 50 end (Figure 4A). However, in the absence of
sarkosyl (Figure 4B), X and autosomes differ at the 50 end of
the metagene, indicating that the population of Pol II engaged
in active transcription at this early point already shows partial
compensation (X > A). These results are consistent with a model
in which release from 50 pausing is a key rate-limiting step in
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Figure 4. Public Data sets Confirm Partial Compensation at Early Steps of Transcription and Augmented Pol II Density at Later Stages
(A and B) Comparison of X (red) and autosomal (blue) Pol II density using recently published data (Core et al., 2012) in which GRO-seq in male (S2) cells was
performed in both the presence and absence of sarkosyl to track paused plus active Pol II (A) or only active Pol II (B), respectively. The average log2 ratio over
genomic sequencing control is shown (top panels) to account for the differences in the copy number for genes on chromosome X or autosomes. The metagene
profile is generated as in Figure 3. The bottom panels show the ratio between the average profiles of the X (n = 398) and autosomes (n = 1,657) reported in the
upper panels.
(C) The top panel shows the metagene profile of the RNA Pol II Ser2P occupancy on the X chromosome and autosomes in S2 cells using published Pol II Ser2P
ChIP-chip data (Regnard et al., 2011). The bottom panel shows the ratio between the average occupancy profiles of the X (n = 507) and autosomes (n = 2,132).
(D) Data for short RNAs associated with paused Pol II from Nechaev et al. (2010) are shown. The average log2 ratio over genomic sequencing control is shown
around transcription start sites (TSS), considering reads from the 50 ends of short RNAs in X-linked (red line; n = 507) and autosomal (blue; n = 2,132) actively
transcribed genes.
(E) Jump start and gain model: Paused Pol II is not augmented on the male X chromosome, but early elongation is increased on the male X relative to autosomes.
Pol II release from pausing and entry into the elongation phase (‘‘jump start’’) is facilitated by X-specific enrichment of H4K16 acetylation in the gene bodies.
H4K16ac levels increase over the bodies of genes, therefore continuing to reduce steric hindrance and leading to a ‘‘gain’’ of progression or processivity of Pol II.
See also Figure S4.transcription, which can be facilitated on male X-linked genes.
Both GRO-seq protocols also confirm a relative increase of Pol
II density along the bodies of genes on X versus autosomes (Fig-
ures 4A and 4B, bottom panels).CeWe also compared X and autosomal levels of pausing from
a published study onmale S2 cells using an alternative approach
in which 50 capped RNAs < 100 bp in length were quantified
(Nechaev et al., 2010). We found that normalized levels ofll Reports 5, 629–636, November 14, 2013 ª2013 The Authors 633
promoter-proximal short RNAs from the X chromosome are
equivalent to autosomal genes, thus further supporting the
GRO-seq results (Figure 4D). Taken together, GRO-seq, short
RNA, and Nascent-seq results from independent data sets all
point to transcriptional elongation as the process that is differen-
tially regulated by DC, starting with pausing release and
continuing along the gene body.
A recently published paper proposed an alternative model in
which RNA Pol II recruitment is the key regulated step, with
initiation, 50 pausing, and all subsequent steps reflecting the
initial increase (Conrad et al., 2012). This was supported by a
2-fold increase of RNA Pol II ChIP at X-linked promoters in
male salivary glands, which was later revised to 1.2-fold after
correction of an erroneous processing step (Ferrari et al.,
2013; Straub and Becker 2013; Vaquerizas et al., 2013).
Notably, the data from Conrad et al. (2012) provide no support
for the elongation model (Ferrari et al., 2013; Straub and Becker
2013; Vaquerizas et al., 2013). Detection of elongation differ-
ences by ChIP might require antibodies specific for elongating
Pol II phosphorylated at serine-2 (Ser2P) (Marshall et al., 1996;
Lee and Greenleaf, 1997). We analyzed published ChIP-chip
data for elongating Pol II Ser2P (possibly in conjunction with
Ser5P) in male S2 cells from the Becker lab (Regnard et al.,
2011), which show a clear increase of Pol II over X-linked
gene bodies (Figure 4C). Taken together, Pol II Ser2P ChIP re-
sults are concordant with our Nascent-seq and GRO-seq
analyses.
In summary, we have systematically dissected themechanism
of DC during distinct steps of transcription. Multiple high-resolu-
tion, genome-wide approaches converge on the followingmodel
(Figure 4E): paused Pol II is not augmented in general on themale
X, but Pol II release from pausing (‘‘jump-start’’ in our model)
appears to be a key rate-limiting step that is facilitated by X-spe-
cific enrichment of H4K16ac in gene bodies. The increasingMSL
and H4K16ac levels over the bodies of genes further reduce
steric hindrance, leading to a ‘‘gain’’ of Pol II density. Currently,
we cannot determine whether this gain is the result of (1)
increased processivity (reduced termination) or (2) positive feed-
back to 50 Pol II, to further increase pausing release. In either
case, we believe that facilitated elongation through an acetylated
chromatin template enables coordinate control of X-linked
genes with widely differing mechanisms of individual, gene-spe-
cific regulation.EXPERIMENTAL PROCEDURES
Cell Culture
S2 and Kc-167 cells were cultured at 25C in Schneider’s medium (Gibco)
supplemented with 10% (v/v) heat-inactivated FBS (JRH).
Nascent RNA Isolation
The isolation of nascent RNA was adapted from Wuarin and Schibler (Wuarin
and Schibler, 1994). See the Supplemental Experimental Procedures for
details.
RNAi
RNAi treatment was performed as described previously (Gelbart et al., 2009;
Larschan et al., 2011). See the Supplemental Experimental Procedures for
details including primer sequences.634 Cell Reports 5, 629–636, November 14, 2013 ª2013 The AuthorsHelicos cDNA-Based Sequencing and Direct Nascent RNA
Sequencing
Nascent transcripts were converted to strand-specific cDNA by random prim-
ing andmodifiedwith a poly-A tail according to the company’s protocol prior to
loading on the HeliScope Single Molecule Sequencer. For DnRS, the recov-
ered nascent RNAs were submitted to Helicos. DnRS sequencing is similar
to the published DRS protocol (Ozsolak et al., 2009), except that DRS was
tailored to sequence polyadenylated mRNAs, whereas in DnRS an additional
step was included before sequencing to add poly(A) tails to the RNA
molecules.
Processing of Nascent-Seq Data
The sequenced reads were filtered and aligned using the Helisphere tools suite
by Helicos (http://sourceforge.net/projects/openhelisphere/). See the Supple-
mental Experimental Procedures.
Gene Annotations and Estimation of Transcriptional Magnitude for
Nascent-Seq and GRO-Seq Data
Refined annotations for mRNA transcripts were obtained from Graveley et al.
(2011). The read count per gene was computed taking into account strand
specificity. Comparison of the read counts between replicates confirmed
good reproducibility (Figure S1B) and replicates were merged. To estimate
transcription magnitude from Nascent-seq data, reads per kilobase per million
mapped reads (RPKM) values were computed adjusting for mappability. The
distribution of RPKM values was examined and RPKMR 2, with at least three
reads, were chosen as thresholds to select actively transcribed genes from
Nascent-seq data. The same procedure was applied to GRO-seq data to
define actively transcribed genes. See also Supplemental Experimental
Procedures.
Metagene Profiles
To compute the average Nascent-seq read-density profile we used normal-
ized Gaussian smoothing of read-mapping positions. Actively transcribed
genes were further filtered by length and distance from neighboring loci.
For cDNA sequencing data, introns were excluded from specific metagene
profiles as reported in the figure legends. Scaling of genes was achieved
by splitting smoothed profiles into 200 bins for each gene and flanking re-
gions, and then computing the average for each bin in individual genes.
Read density was then log2 transformed, after adding a pseudocount of 1
to each bin to avoid log transformation of zero values. The value of the
Nth bin in the metagene profile is then the average of the log2 read density
in the Nth bins across the gene set. The same procedure was used for un-
scaled metagene profiles centered at gene ends, but equally sized bins
were used. For GRO-seq data, the average log2 ratio between GRO-seq
and genomic control read densities was computed for each gene and for
each bin to facilitate comparison with other public data sets (ChIP-chip
and short RNAs) (Figure 4). See the Supplemental Experimental Procedures
for more details.
ChIP-chip Data
The data set for Pol II ser-2P ChIP-chip profiles used in this study were
obtained from Regnard et al. (2011). To determine gene expression level, we
used public RNA-seq data (GSE15596 in the Gene Expression Omnibus).
See also Supplemental Experimental Procedures.
ACCESSION NUMBERS
The sequencing data were deposited in the Sequence Read Archive under
accession number for SRA062950.
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and four figures and can be found with this article online at http://dx.doi.org/
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